Government Properties Income Trust (GOV) 23.29

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Government Properties Income Trust (GOV) 23.29 $GOV

Equity REITs higher across the board after Fed
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 2:28PM CDT

FRI: 23.86 (+0.59), WREI: 48.58 (+0.93), DLR: 68.28 (+1.73), SHO: 17.29 (+0.34), PSA: 199.12 (+4.88), PPS: 58.47 (+1.57), AIV: 41.19 (+1.14), EQC: 26.90 (+0.55), SNH: 22.98 (+0.70), SRC: 12.26 (+0.15), GOV: 23.29 (+0.51), ACC: 43.76 (+1.50), SCHH: 41.83 (+1.03), DRV: 19.91 (-1.64), KIM: 27.74 (+0.75), REK: 19.01 (-0.44), IYR: 81.96 (+1.94), DRN: 95.15 (+6.58), URE: 119.25 (+5.43), VNQ: 87.03 (+2.13), HTA: 29.02 (+1.08), SRS: 10.96 (-0.53), RWR: 97.05 (+1.96), NNN: 42.29 (+1.11), FTY: 50.09 (+0.95), ICF: 104.51 (+2.44), DDR: 19.33 (+0.43), FPO: 12.12 (+0.14), LPT: 37.13 (+0.88), PSR: 77.48 (+1.51), GPT: 7.37 (+0.23), KBWY: 36.70 (+0.89), FREL: 24.47 (+0.36)

Get 37.35% Leverage In 5 REIT Highest Yield, Lowest Price, March 13 Stocks
Fredrik Arnold - at Seeking Alpha - Tue Mar 17, 9:00AM CDT

GOV: 23.29 (+0.51), RSO: 4.74 (-0.03), SIR: 25.57 (+0.73), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), IRT: 9.50 (+0.03), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), JMI: 8.42 (-0.12), CORR: 7.03 (+0.25)

REITs: Yield To 18.48%, Upside To 26.9%, Gains To 40.6% As Of 3/13/15
Fredrik Arnold - at Seeking Alpha - Tue Mar 17, 8:39AM CDT

RSO: 4.74 (-0.03), SIR: 25.57 (+0.73), AHH: 10.93 (-0.01), IRT: 9.50 (+0.03), AHT: 10.16 (+0.27), GOV: 23.29 (+0.51), STAG: 24.62 (+0.56), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), MNR: 11.32 (+0.26), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), CORR: 7.03 (+0.25), JMI: 8.42 (-0.12)

Nothing But Net Lease REITs: March Madness Has Arrived
Brad Thomas - at Seeking Alpha - Thu Mar 12, 6:00AM CDT

LXP: 10.39 (+0.18), OLP: 25.60 (+0.70), GTY: 18.57 (+0.32), NNN: 42.29 (+1.11), O: 53.65 (+1.41), SRC: 12.26 (+0.15), STAG: 24.62 (+0.56), CSG: 7.94 (+0.13), GOV: 23.29 (+0.51), STOR: 23.55 (+0.88), WPC: 70.82 (+1.48), GPT: 7.37 (+0.23), MNR: 11.32 (+0.26), ARCP: 10.09 (+0.23), EPR: 61.78 (+1.47)

Three Buy-Rated Dividend Stocks To Check Out: CTL, POT, GOV
at The Street - Tue Mar 10, 10:32AM CDT
These three dividend stocks are rated a Buy by TheStreet
GOV: 23.29 (+0.51), POT: 32.40 (+0.36), CTL: 35.30 (+0.44)

48.97% Edge For 5 REIT Highest-Yield, Lowest-Priced, March Issues
Fredrik Arnold - at Seeking Alpha - Wed Mar 04, 3:12AM CST

STAG: 24.62 (+0.56), GOV: 23.29 (+0.51), SIR: 25.57 (+0.73), ARR: 3.24 (+0.05), HPT: 33.97 (+1.04), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), WSR: 16.32 (+0.41), SNH: 22.98 (+0.70), CORR: 7.03 (+0.25)

Beware The REITs Of March: 18.42% Yield; 19.55% Upside; 25.98% Net Gain
Fredrik Arnold - at Seeking Alpha - Wed Mar 04, 2:38AM CST

RSO: 4.74 (-0.03), SIR: 25.57 (+0.73), IRT: 9.50 (+0.03), AHT: 10.16 (+0.27), HPT: 33.97 (+1.04), WSR: 16.32 (+0.41), SNH: 22.98 (+0.70), STAG: 24.62 (+0.56), GOV: 23.29 (+0.51), ARR: 3.24 (+0.05), RESI: 21.19 (+0.13), MNR: 11.32 (+0.26), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), ORC: 13.68 (+0.08), ADC: 34.17 (+0.67), CORR: 7.03 (+0.25), JMI: 8.42 (-0.12)

Portnoys pay greenmail to make activist go away
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 7:42AM CST

GOV: 23.29 (+0.51), SIR: 25.57 (+0.73)

Government Properties Income Trust Increases Investment in Select Income REIT
Business Wire - Mon Mar 02, 7:00AM CST
Government Properties Income Trust (NYSE: GOV) today announced that it has entered an agreement to purchase 3,418,421 common shares of Select Income REIT (NYSE: SIR) from a fund affiliated with Lakewood Capital Management, LP ("Lakewood". The purchase price is approximately $95.2 million, or $27.85 per share. As a result of this purchase, GOV's ownership of SIR will increase from approximately 24.3% to approximately 28.2% of the total common shares of SIR.
GOV: 23.29 (+0.51), SIR: 25.57 (+0.73)

Government Properties Income Trust (GOV) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 20, 4:55PM CST

GOV: 23.29 (+0.51)

Government Properties FFO in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 7:04AM CST

GOV: 23.29 (+0.51)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 4:30PM CST

SATS: 51.90 (+0.89), ERF: 9.88 (+0.24), HCN: 79.13 (+2.35), PNW: 64.73 (+0.74), PEG: 42.11 (+0.24), B: 40.37 (+0.15), IRM: 38.65 (+0.38), SWC: 13.69 (+0.54), GOV: 23.29 (+0.51), CHH: 64.85 (+0.14), COG: 28.69 (+0.37), COMM: 30.86 (+0.25), DE: 89.18 (+1.10), TFX: 119.98 (+0.07), LH: 126.80 (+0.54), ENB: 48.44 (+0.65), TC: 1.43 (+0.04), IPGP: 100.00 (+0.07)

Should You Buy Government Properties (GOV) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 7:30AM CST
Investors are always looking for stocks that are poised to beat at earnings season and Government Properties may be one such company as the firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
GOV: 23.29 (+0.51)

Buy-Rated Dividend Stocks: Top 3 Companies: HME, GOV, BX
at The Street - Fri Feb 13, 9:38AM CST
These 3 dividend stocks are rated a Buy by TheStreet
GOV: 23.29 (+0.51), HME: 71.89 (+2.09), BX: 38.69 (unch)

Government Properties Income Trust: The Government Really Is Here To Help
James Bjorkman - at Seeking Alpha - Thu Feb 12, 11:36AM CST

GOV: 23.29 (+0.51)

Government Properties Income Trust Fourth Quarter Conference Call Scheduled for Friday, February 20th
Business Wire - Mon Feb 09, 7:00AM CST
Government Properties Income Trust (NYSE: GOV) today announced that it will issue a press release containing its fourth quarter and year end 2014 financial results before the NYSE opens on Friday, February 20, 2015. Later that afternoon, at 1:00 p.m. Eastern Time, President and Chief Operating Officer David Blackman and Chief Financial Officer Mark Kleifges will host a conference call to discuss these results.
GOV: 23.29 (+0.51)

REITs Get 85.12% Leverage From 5 Lowest Priced High Yield February Dividend Dogs
Fredrik Arnold - at Seeking Alpha - Sat Feb 07, 3:35AM CST

GOV: 23.29 (+0.51), DFT: 34.72 (+1.31), SIR: 25.57 (+0.73), ARR: 3.24 (+0.05), HPT: 33.97 (+1.04), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), ARCP: 10.09 (+0.23), SNH: 22.98 (+0.70), CORR: 7.03 (+0.25)

Ruling REITs Of February: 20.8% Yield; 30.6% Upside; And 35.6% Net Gain
Fredrik Arnold - at Seeking Alpha - Fri Feb 06, 5:55PM CST

RSO: 4.74 (-0.03), SIR: 25.57 (+0.73), IRT: 9.50 (+0.03), AHT: 10.16 (+0.27), HPT: 33.97 (+1.04), SNH: 22.98 (+0.70), GOV: 23.29 (+0.51), HASI: 18.93 (+0.53), DFT: 34.72 (+1.31), ARR: 3.24 (+0.05), WMC: 15.53 (+0.21), WHLR: 2.63 (-0.08), ARCP: 10.09 (+0.23), ORC: 13.68 (+0.08), CORR: 7.03 (+0.25), UMH: 10.24 (+0.25)

Income favorites ponder the idea of rate hikes
Seeking Alpha - at Seeking Alpha - Fri Feb 06, 9:19AM CST

FRI: 23.86 (+0.59), SPG: 197.34 (+5.24), WREI: 48.58 (+0.93), O: 53.65 (+1.41), VTR: 73.73 (+1.87), GOV: 23.29 (+0.51), CSG: 7.94 (+0.13), ACC: 43.76 (+1.50), SCHH: 41.83 (+1.03), IRC: 10.98 (+0.25), DRV: 19.91 (-1.64), REK: 19.01 (-0.44), IYR: 81.96 (+1.94), DRN: 95.15 (+6.58), URE: 119.25 (+5.43), VNQ: 87.03 (+2.13), SRS: 10.96 (-0.53), HCP: 42.44 (+1.20), RWR: 97.05 (+1.96), NNN: 42.29 (+1.11), HPT: 33.97 (+1.04), EXR: 69.22 (+2.29), FRT: 149.44 (+3.04), FTY: 50.09 (+0.95), ICF: 104.51 (+2.44), GGP: 31.00 (+0.42), WRE: 28.38 (+0.82), EQY: 27.49 (+0.44), ESS: 240.55 (+5.71), OHI: 40.67 (+0.75), PSR: 77.48 (+1.51), KBWY: 36.70 (+0.89)

What Investors Need to Know About the Easterly Government Properties' IPO
Eric Volkman, The Motley Fool - Motley Fool - Thu Feb 05, 7:00AM CST
The stock market is crammed with a great many real estate investment trusts of every conceivable dimension and size. So much so that an investor could be forgiven for asking if there's really any need for yet another one. The folks backing ...
GOV: 23.29 (+0.51)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading